Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 61 results for "ajanta pharma"

Ajanta Pharma ranks 3rd largest wealth creator

In Fortune India's rankings for 500 Mid Size Companies Business Standard, 1 week ago

Super Six short term picks for September 2

Provided by 6 trading stocks for short term gain On CNBC-TV18's show Super Six, market gurus Manav Chopra, Meghana Malkan and Gaurav Bissa, place their bets on two stocks each, thus offering investors a variety of options to ...
 MSN News US1 day ago
Business Insider India

Top Stock Market action to watch out for today

The Nifty will experience selling pressure at the start of trade on Tuesday as weak overseas cues and a rise on crude oil prices hold back traders from taking long positions on local stocks. Auto and cement companies will be in focus as they report ...
 Business Insider India2 days ago
Business Insider India

ICICI Securities recommends you buy these shares

Retail brokerage ICICI Securities has come up with a list of stocks to purchase to benefit from this sharp downturn in equities which has seen the Nifty fall more than 11 percent since August 11th as a global sell-off in risk assets hit stock ...
 Business Insider India1 week ago
The Freepress Journal

Stock Market Predictions The Fed is still caught between two minds

08:50 am A swift, steep drop in yesterday's early morning session at Dalal Street flipped to gains, on backdrop of latest signal that Beijing will not let the market fall too sharply before engineering a rescue. The Shanghai Composite Index which ...
 The Freepress Journal2 weeks ago
India Infoline

Top Pharma news of the day

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has received final approval for its 3 ANDAs (Abbreviated New Drug Application) by US FDA (United States Food and Drug Administration)
 India Infoline4 weeks ago Ajanta Pharma in the pink of health  Business Standard4 weeks ago Ajanta Pharma gets US FDA approval for 3 ANDA's  HT Syndication4 weeks ago Ajanta Pharma shines on getting approvals for 3 ANDAs  Finalaya.com4 weeks ago

Ajanta Pharma to hold board meeting

On 13 August 2015
 Business Standard1 month ago Ajanta Pharma informs about Board Meeting  Finalaya.com1 month ago Ajanta Pharma's Q1 results on August 13, 2015  Money Control1 month ago Ajanta Pharma: Updates on outcome of AGM  Money Control1 month ago
Business Insider India

Shares of Ajanta Pharma are edging closer to record highs. Know why

Join the discussion with Business Insider Refrain from posting comments that are obscene, libellous, slanderous or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Let's work together to ...
 Business Insider India3 weeks ago

Indian Pharamaceutical Company Receives USFDA's Nod for Asthma Treatment Drugs

US Food and Drug Administration (FDA) has approved Ajanta Pharma to market its generic montelukast tablets and oral granules. It is used for the prevention and treatment of asthma and also to relieve symptoms of seasonal hay fever. "The company ...
 MedIndia4 weeks ago

Ajanta Pharma gets USFDA nod for generic asthma treatment drug

Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules used for prevention and treatment of asthma and to relieve symptoms of seasonal hay fever. The company has "received ...
 Business Standard4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ajanta pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less